Quest Diagnostics (DGX) net income: $992M
Quest Diagnostics reported a net income of $992M for the year ended Dec 31, 2025, up 13.9% from $871M a year earlier.
From Quest Diagnostics's filings with the SEC · Read the filing · DGX stock page
Quest Diagnostics net income by year
#379 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $992M | +14% |
| Dec 31, 2024 | $871M | +2% |
| Dec 31, 2023 | $854M | -10% |
| Dec 31, 2022 | $946M | -53% |
| Dec 31, 2021 | $2B | – |
Net income of similar companies
Companies in the same industry as Quest Diagnostics, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Quest Diagnostics | $992M | Dec 31, 2025 |
| Labcorp | $877M | Dec 31, 2025 |
| Veracyte | $66.4M | Dec 31, 2025 |
| BillionToOne | $7.5M | Dec 31, 2025 |
| Freenome | $837K | Dec 31, 2025 |
| Natera | −$208M | Dec 31, 2025 |
| Guardant Health | −$416M | Dec 31, 2025 |
Questions and answers
What is Quest Diagnostics's net income?
Quest Diagnostics reported a net income of $992M for the year ended Dec 31, 2025, up 13.9% from $871M a year earlier.
Numbers as reported in Quest Diagnostics's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology